Page no	Column/paragraph	line	Present word	Change to
1	Abstract/results	2	of	above
2	1/2	2	Cyclic	Cyclin
2	2/1	3	VEGFR	VEGFR-2
12	2/1	3	prognosis	progression
12	2/1	10	form	from
19	Above conclusions	4	Cyc919	Cys919
10	2/1	13	20 ps	20 ns
10	2/1	15	25 ps	25 ns
13	2/1	6	four	five
Table 5/ reference	van der Waals interactions	–	asn900leu1044	Asn900, Ile1044
Fig 10	–	–	30 ps	30 ns
Fig 16	–	–	refrence	reference